Guerbet SA is a healthcare company that develops and commercializes contrast agents, injection systems, medical devices, and digital solutions for diagnostic imaging and interventional radiology. The company operates in three main business segments: Diagnostic Imaging, Interventional Radiology, and Digital & AI. Its product portfolio includes iodinated and gadolinium-based contrast agents for X-ray and MRI, as well as injectors and embolization devices. Key brands include Lipiodol, Dotarem, Xenetix, and Elucirem. Guerbet also offers AI-based diagnostic support tools through its subsidiary Intrasense, including DUOnco Pancreas and Liflow. The company serves healthcare professionals globally. Guerbet was founded in 1926 and acquired Mallinckrodt's contrast and injection systems business in 2015 to expand its international footprint.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Medical Devices Homepage guerbet.com
Sector Healthcare IR page guerbet.com/investors
Tags
contrast agents, diagnostic imaging, interventional radiology, medical devices, artificial intelligence, oncology, radiology, injection systems, embolization, healthcare, Lipiodol, Dotarem, Xenetix, Elucirem, Intrasense, DUOnco Pancreas, Liflow, OptiStar Elite, OptiVantage, Angiomat Illumena, Lipiojoint
Press page —

Metrics

Valuation  
Market cap € 97.86M
Market cap (USD) $ 108.889M
P/E -0.70
PEG —
P/BV 0.42
P/S 0.11
P/OCF 1.36
P/FCF 1.91
Dividend yield 10.6%
Turnover / mcap —
Returns  
ROE -33.2%
ROI -41.7%
ROIC -25.4%
Profit margin -13.8%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable No
Margin expanding No
Buying back stock Yes
Diluting (TTM) —
Debt/Equity 208.2%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 36
Quality score -29.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2011 FY 2010
Revenue 786.443M 841.093M 785.69M 753.275M 732.071M 712.295M — —
Net profit -108.331M 16.084M 23.866M -41.116M 32.637M 18.24M — —
Free cash flow 51.227M 49.175M -14.118M -13.394M 78.473M 80.64M — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2011 FY 2010
Share price 15 26.28 19.55 — — — — —
Price performance 12m -0.43 0.34 — — — — — —

Filed figures

Figure Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Cash and deposits (EUR) 96.7M 116M 41.7M 51.3M 50.2M 116M
Intangible assets (EUR) 188M 189M — — — —
Cash flow detail
Operating cash flow (EUR) 120M 116M 30.4M 27.4M 81.2M 81.1M
Purchases of property, plant and equipment (EUR) -39.8M -37.5M -43.8M -41.6M -32M -29.9M
Purchases of intangible assets (EUR) -19.9M -11.4M -6.69M -12.5M -24.9M -6.75M
Change in receivables (cash effect) (EUR) 14M -6.64M -1.56M -29M -27.3M 27.3M
Change in inventories (cash effect) (EUR) 17.4M 4.58M -68.2M -36.3M -6.57M -18.6M
Change in payables (cash effect) (EUR) 4.61M 16M 22.1M -10.3M 1.89M -7.04M
Dividends paid (cash effect) (EUR) -8.83M -8.81M -10.7M -6.31M -6.31M 0.00
Interest paid (cash effect) (EUR) -4.89M -5.25M -4.55M -10.6M -20.5M -19.8M
Share-based compensation (EUR) -1.31M 610,000 -399,000 205,000 717,000 -680,000
Operating cash flow before change in receivables (EUR) 106M 123M 32M 56.4M 109M 53.8M
Free cash flow (OCF - PPE - intangibles) (EUR) 60.8M 67M -20.1M -26.6M 24.2M 44.5M
Income detail
Total comprehensive income (EUR) -17M 44.6M -12.4M 492,000 19.6M -128M
Comprehensive income to owners (EUR) — — — 2.19M 22.2M -124M
Reported Apr 5, 2022 Apr 5, 2022 Mar 31, 2023 Apr 3, 2025 Apr 3, 2025 Mar 20, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Guerbet : Revenue at 30 September 2026. Bull 1 Bear 4 Results

Prompts

Guerbet SA (ticker GBT), listed in France.

ETFs Holding Guerbet SA

ETF Weight in ETF Shares Market value As of
DISV 0.00% 9,744 $ 73.973K Nov 12, 2026
DFIC 0.00% 5,225 $ 39.666K Nov 12, 2026
AVDE 0.00% 463 $ 3,330.93 Nov 16, 2026
AVSD 0.00% 74 $ 532.37 Nov 16, 2026